IEQ Capital’s AtriCure ATRC Stock Holding History

IEQ Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	41,484 +33,532	+422%	+$944K	0.01%	1046
2026 Q1	$227K	Buy	+7,952	New	+$271K	﹤0.01%	1637

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

IEQ Capital's ATRC Position: Q2 2026 in Review

IEQ Capital increased its AtriCure (ATRC) stake by 422% in Q2 2026, buying an estimated $944K and bringing the position to 41,484 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1046.

IEQ Capital first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

IEQ Capital held 41,484 shares of AtriCure worth $1.16M as of Q2 2026.
IEQ Capital bought 33,532 AtriCure shares in Q2 2026, an estimated $944K.
AtriCure made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #1046 holding.
IEQ Capital first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.